Selective reagent ionisation-time of flight-mass spectrometry: a rapid technology for the novel analysis of blends of new psychoactive substances

2015 ◽  
Vol 50 (2) ◽  
pp. 427-431 ◽  
Author(s):  
Matteo Lanza ◽  
W. Joe Acton ◽  
Philipp Sulzer ◽  
Kostiantyn Breiev ◽  
Simone Jürschik ◽  
...  
2019 ◽  
Vol 38 (1) ◽  
pp. 269-276 ◽  
Author(s):  
Zhenhua Qian ◽  
Cuimei Liu ◽  
Jian Huang ◽  
Qingqing Deng ◽  
Zhendong Hua

Abstract Purpose This publication reports analytical properties of the designer benzodiazepine 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine (flualprazolam) seized in an anesthesia robbery case. Methods The target compound was identified by liquid chromatography–quadrupole time-of-flight-mass spectrometry (LC–QTOF-MS), gas chromatography–mass spectrometry (GC–MS), and nuclear magnetic resonance (NMR) spectroscopy. Results We could obtain detailed analytical data of flualprazolam—a new designer benzodiazepine available on the designer drug market. Conclusions More designer benzodiazepines have been detected and seized on the illegal drug scene as new psychoactive substances during the last 5 years. In this study, we presented analytical data of flualprazolam to assist forensic laboratories that encounter these newly emerging compounds in casework. This is the first report on this compound in illegal products.


2019 ◽  
Vol 40 (3) ◽  
pp. 135-146 ◽  
Author(s):  
Darren Allen ◽  
Brett McWhinney

The screening of biological samples for the presence of illicit or legal substances is an important frontline tool in both clinical and forensic toxicology. In the clinical setting, drug screening is a useful tool for the clinician in improving patient care and guiding treatment. Analytical approaches for the screening of drugs in biological samples are extensive and well documented, though many rapid screening techniques often lack appropriate sensitivity and specificity, requiring careful clinical interpretation. The continuous emergence of new psychoactive substances presents a considerable analytical challenge in maintaining up-to-date methods for the detection of relevant drugs. Adapting and validating methods for the detection of new substances can be a complicated and costly undertaking. There is also a considerable lag time between the emergence of new drugs and the release of commercial assays for detection. Quadrupole time-of-flight mass spectrometry (Q-TOF-MS) has gained considerable attention over the last decade as an analytical technique that is capable of meeting the challenges of a rapidly changing drug landscape. Exhibiting both high sensitivity and specificity in drug detection, Q-TOF-MS also allows methods to be rapidly updated for newly emerging psychoactive agents. The coupling of Q-TOF-MS with techniques such as liquid or gas chromatography can provide both rapid and comprehensive screening solutions that are gaining popularity in the clinical laboratory setting.


2017 ◽  
Vol 421 ◽  
pp. 40-50 ◽  
Author(s):  
Dušan Materić ◽  
Matteo Lanza ◽  
Philipp Sulzer ◽  
Jens Herbig ◽  
Dan Bruhn ◽  
...  

The Analyst ◽  
2016 ◽  
Vol 141 (15) ◽  
pp. 4796-4803 ◽  
Author(s):  
Paweł Mochalski ◽  
Karl Unterkofler

Selective reagent ionization time of flight mass spectrometry with NO+as the reagent ion in conjunction with gas chromatography and head-space solid-phase microextraction was used to determine 16 volatiles in human urine.


2020 ◽  
Vol 12 (40) ◽  
pp. 4878-4884
Author(s):  
Jian Li ◽  
Junmei Ma ◽  
Yan Zhang ◽  
Lei Zheng

In this study, a method for the qualification and quantification of 4 psychoactive substances in tea using ultra high performance liquid chromatography coupled with the quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS) has been developed.


Sign in / Sign up

Export Citation Format

Share Document